what is Cinacalcet hcl powder ?
Cinacalcet Hcl powder is a specific drug for controlling hyperparathyroidism and inhibiting parathyroid hormone PTH. It has now become a first-line drug in most parts of China. However, as it is a new drug, doctors in many places do not have much experience in medication, and because many patients have been taking Indian generic drugs without seeing the instructions, they are relatively blind in medication and the effect of medication is not very good.
![]() |
Product name |
Cinacalcet hcl |
|
CAS |
364782-34-3 |
|
|
Molecular formula |
C22H23ClF3N | |
|
Molecular weight |
393.88 | |
|
EINECS Number |
620-490-5 | |
|
Storage condition |
Inert atmosphere,2-8°C | |
|
Appearance |
White powder | |
|
Melting point |
175-177°C | |
| Solubility | Insoluble in water; DMSO ≥17.85 mg/mL; Ethanol ≥ 56 mg/mL |
What are the uses of Cinacalcet hcl powder?

Cinacalcet Hcl powder is a calcium mimetic that can improve the disorder of bone metabolism in uremic patients and delay the progression of vascular and valve calcification in dialysis patients. However, long-term use of cinacalcet can also cause side effects such as nausea and vomiting, hypocalcemia, and excessive inhibition of parathyroid hormone (PTH)
The characteristic of Cinacalcet hcl powder is not only to reduce the overall serum PTH level, but also to reduce the levels of serum calcium, serum phosphorus, and serum calcium phosphorus product.
It can inhibit the occurrence and progression of cardiovascular diseases caused by ectopic calcification.
If you need it, pls click e-mail sales1@faithfulbio.com
Product Specification
|
Test Items |
Specification |
Test Result |
|
Appearance |
White to Yellow to Beige |
white |
|
Identification |
||
| Complies |
Complies |
|
|
Optical Rotation |
-32.0 - -24.0 ° |
-29.3° |
|
water |
0.0 - 3.0 mol |
0.0 |
|
Salt Content |
0.9-1.1mol |
1mol |
|
Elemental Composition |
pass |
pass |
|
Assay(on anhydrous basis) |
≥ 97.5 % |
99.9% |
What are the relevant studies on Cinacalcet Hcl powder?
In vitro
Cinacalcet HCl powder represents a new type of compound used to treat hyperthyroidism, which is a calcium mimetic agent that reduces the synthesis and secretion of parathyroid hormone (PTH) by increasing the sensitivity of parathyroid calcium sensitive receptors (CaR) to extracellular calcium ions. Cinacalcet HCl, as a therapeutic agent for secondary hyperparathyroidism, has potential advantages because it simulates the action of extracellular calcium ions to inhibit PTH secretion, and even in cases of hyperphosphatemia, there is no risk of causing hypercalcemia and/or hyperphosphatemia. CinacalcetHCl induces a concentration dependent increase in calcium ions in the cytoplasm of human embryonic kidney cells expressing CaSR. In bovine parathyroid cells and a buffer containing 0.5 mM calcium and AMG073 (3nM – 1 μ M), PTH levels were reduced concentration dependently, with an IC50 of 27 nM.
In vivo
oral administration of Cinacalcet HCl powder at doses of 1, 3, 10, and 30 mg/kg in 20% sulfobutyl ether β - cyclodextrin sodium in normal rats resulted in a significant dose-dependent decrease in PTH levels after 1 to 4 hours of administration. At 8 hours, compared with the control group, Cinacalcet HCl at doses of 10 and 30 mg/kg significantly reduced PTH levels, and this effect disappeared at 24 hours. Cinacalcet HCl was orally administered at doses of 3, 10, and 30 mg/kg, and significant reductions in serum calcium levels were observed at 4, 8, and 24 hours, respectively. The transient decrease in serum phosphorus levels can only be observed at high doses of Cinacalcet HCl. In addition, in rats, an increase in calcitonin levels was observed at a concentration of 40 mg/kg Cinacalcet HCl, accompanied by inhibition of PTH. In normal rats, rapid dose-dependent reductions in PTH and calcium levels were observed in 5 out of 6 nephrectomized rats after oral administration of Cinacalcet HCl. In addition, compared with the control group, oral administration of 5 and 10 mg/kg Cinacalcet HCl for 4 weeks significantly reduced the weight of parathyroid glands.
What are the adverse reactions of Cinacalcet Hcl powder?
The adverse reactions of taking Cinacalcet HCl powder mainly include digestive system symptoms such as nausea and vomiting (21.6%, 124/573 cases) and stomach discomfort (18.7%, 107/573 cases)
How and where to buy Cinacalcet Hcl powder wholesale?
We have 8 years of experience in selling legal scientific research drugs and have a good reputation, making us a trustworthy partner.
We ensure the quality of our products through independent experimental testing, and every customer is our VIP.
Send your Inquiry for more information, Click email:sales1@faithfulbio.comNow.





A variety of shipping methods for you to choose
|
Transportation Time |
Shipping method |
Cargo weight requirements |
Advantage |
|
3-7 days |
DHL, Germany DHL, Germany DPD, |
Suitable for under 50kg. |
We have warehouses in Germany and California, USA, |
|
7-15 days |
By Air |
Suitable for more than 50kg. |
|
|
15-60 days |
By Sea |
Suitable for more than 500kg. |
Disclaimer: The articles on this website are mainly used for scientific research and academic exchange. Please carefully discern the authenticity of their viewpoints and content. If you discover any infringement. Please contact the administrator promptly. We are not responsible for the consequences of the information and services provided on this website.
Note: The product is for research use only and is not intended for diagnosis, treatment, disease prevention, etc.
Send your Inquiry for more details, Click email:sales1@faithfulbio.com Now.
Hot Tags: cinacalcet hcl powder cas 364782-34-3, China, suppliers, manufacturers, factory, customized, wholesale, buy, price, bulk, pure, producer, discount, for sale, in stock, free sample, raw powder, raw material, made in China







